DONATE

Search Results for:

IBEC researchers find a new way to effectively transport drugs to the brain

An international group of researchers from the University of Maryland (United States) and the Institute for Bioengineering of Catalonia (IBEC) led by ICREA Research Professor Silvia Muro, has identified a new way of transporting drugs to the brain, one of the major challenges of the pharmaceutical science today, that could help to come up with new treatments for neurological diseases such as Parkinson’s or Alzheimer’s.

To find this out, the experts linked an antibody capable of recognizing the ICAM-1 protein -a molecule expressed on the surface of blood vessels- to a series of polymeric nanoparticles that can transport drugs and inject them intravenously.

Head of Tech Transfer and Business Development Office

Application Deadline: 30/06/2020
Ref: TTO_DB
IBEC seeks a Head of Tech Transfer and Business Development. The successful candidate will be responsible for designing, developing and executing an overall strategy to scout new discoveries and results in the institute, support IBEC’s scientists during technology valorization and intellectual property development, and commercialize those results to ensure beneficial impact on society.

The office will support the IBEC technology and business development capacity and will boost communication between IBEC community and external stakeholders in the innovation arena.

The Head of Tech Transfer and Business Development Office runs a team of 2 people and reports to the Managing Director and is part of the Institute’s senior management team.

Research centres in Catalonia have conducted 20,000 PCR tests to date

The Center for Genomic Regulation (CRG), the National Center for Genomic Analysis (CNAG-CRG), part of CRG, the Institute for Research in Biomedicine (IRB Barcelona) and the Institute for Bioengineering of Catalonia (IBEC) have analysed more than 20,000 samples to date using the PCR technique. In this regard, 17,547 samples have been tested at the CRG node and 5,248 at the PCB node.

The analyses are part of the Orfeu Programme, the mass screening initiative driven by the Government of Catalonia. As of today, the public health system in Catalonia can carry out up to 17,000 PCR tests every day. This number does not include the capacity of the Orfeu Programme, which can process up to 4,000 samples per day.

Practicant Web a la Unitat de Comunicació i Divulgació

Application Deadline: 11/06/2020
Ref: COM_GO
L’Institut de Bioenginyeria de Catalunya (IBEC) requereix incorporar un/-a estudiant en pràctiques a la unitat de Comunicació i Divulgació de l’IBEC per donar suport en l’àmbit de l’entorn web.

IBEC receives funding from Carlos III Health Institute to fight COVID-19 using bioengineering

The COVID-19 Fund managed by the Carlos III Health Institute has awarded more than 300,000 euros to the “ACE2-ORG” project led by ICREA research professor Núria Montserrat at IBEC.

The resources are intended to study COVID-19 and specify new therapeutic approaches against the SARS-CoV-2 coronavirus, the Karolinska Institute in Sweden, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, the Hospital Clínic de Barcelona and the University of Navarra also participate in this project.

IBEC supports the EU initiative “Coronavirus Global Response”

The Institute for Bioengineering of Catalonia (IBEC) supports the EU initiative to pledge funds for collaborative development of solutions against COVID19. Carmen Hurtado, from the Group of ICREA Professor Núria Montserrat at IBEC contributes to spread the word of “Coronavirus Global Response” initiative in a video for the European Commission.

The European Union and its partners are hosting an international pledging marathon that started last Monday 4 May 2020 and will be running until the end of May 2020.

Communications Officer

Application Deadline: 31/05/2020
Ref: COT_GO
The Communications Unit is looking for a Communication Officer to reinforce the international reputation of IBEC and provide support to European Projects coordinated by the Institute.
This position will be funded by H2020 European Union programme.

IBEC researchers explain “Durotaxis”, a cell migration mechanism with a potential role in several diseases

Xavier Trepat, group leader of the “Integrative cell and tissue dynamics” at IBEC together with Raimon Sunyer, Senior researcher in Trepat’s lab, have written a Primer in Current Biology magazine on “Durotaxis”, a cell migration mechanism that might have a role in several disease states that include the stiffening of tissues.

Embryo development, tumour progression or the immune response against pathogens requires cell migration.

IBEC’s director contributes to the new National Agreement for a Knowledge-based Society

On May 13, the new National Agreement for a Knowledge-based Society was presented at the appearance of the President of the Catalan Government and the Minister for Business and Knowledge.

This pact proposes the public policies that would have to be carried out so that Catalonia to becomes a leader in research and innovation at the international level.

© 2025 Institute for Bioengineering of Catalonia
Cookies
Cookie Consent The IBEC website uses cookies and similar technologies to ensure the basic functionality of the site and for statistical and optimisation purposes. It also uses cookies to display content such as YouTube videos that use marketing cookies. This last category consists of tracking cookies: these make it possible for your online behaviour to be tracked. You consent to this by clicking on Accept. Also read our Privacy statement. Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all